Substituted benzazoles and use thereof as RAF kinase inhibitors
Details for Australian Patent Application No. 2003226211 (hide)
International Classifications
Event Publications
7 August 2003 Complete Application Filed
Priority application(s): 60/369,066 29.03.02 US
20 November 2003 Application Open to Public Inspection
Published as AU-B-2003226211
29 May 2008 Application Accepted
Published as AU-B-2003226211
12 June 2008 Assignment before Grant
Chiron Corporation The application has been assigned to Novartis Vaccines and Diagnostics, Inc.
25 September 2008 Standard Patent Sealed
27 November 2008 Alteration of Name
The name of the patentee has been altered to Novartis Vaccines and Diagnostics, Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser